# Intravitreal Celecoxib for Chronic Uveitis

> **NCT02131012** · PHASE1 · TERMINATED · sponsor: **Vanderbilt University** · enrollment: 4 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Intravitreal Celecoxib

## Key facts

- **NCT ID:** NCT02131012
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2016-11-01
- **Final completion:** 2016-11-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Difficulty recruiting
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02131012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02131012, "Intravitreal Celecoxib for Chronic Uveitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02131012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*